/
KVUE
$19.30-$0.48 (-2.43%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
3
institutions
Market cap
$37.1B
1,920M shares
52-week range
$14.02 – $22.29
64% from low
Sector
PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS
Exchange
NYSE
CS
Change$-7.59
Kenvue Inc.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
www.kenvue.com- Employees
- 22,000
- IPO / List date
- May 4, 2023
- HQ
- SUMMIT, NJ
Held by traders on TradeandTell
No one on the platform currently holds KVUE.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 4,141,512 | $71.4M |
| Third Point LLCas of 2025-12-31 | 3,250,000 | $56.1M |
Dividend history
TTM yield · 4.31% ($0.83/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-08-12 | $0.2100 | 2026-08-26 |
| 2026-05-13 | $0.2075 | 2026-05-27 |
| 2026-02-11 | $0.2075 | 2026-02-25 |
| 2025-11-12 | $0.2075 | 2025-11-26 |
| 2025-08-13 | $0.2075 | 2025-08-27 |
| 2025-05-14 | $0.2050 | 2025-05-28 |
| 2025-02-12 | $0.2050 | 2025-02-26 |
| 2024-11-13 | $0.2050 | 2024-11-27 |
| 2024-08-14 | $0.2050 | 2024-08-28 |
| 2024-05-07 | $0.2000 | 2024-05-22 |
Recent trades on TradeandTell
No one on the platform has traded KVUE yet.
